Stem Cell-Derived Regulatory T Cells for Therapeutic Use in Arthritis

Overview

Journal Autoimmune Infect Dis

Date 2017 Jan 3

PMID 28042612

Authors

Jianxun Song

Affiliations

Soon will be listed here.

Abstract

Pluripotent stem cells (PSCs) can be utilized to obtain a renewable source of healthy regulatory T cells (T) to treat autoimmune arthritis as they have the ability to produce almost all cell types in the body, including T. However, the right conditions for the development of antigen (Ag)-specific T from PSCs (, PSC-T) remain unknown. An ongoing project will determine the mechanisms underlying the Ag-specific PSC-T treatments that aim to modulate tolerance in autoimmune arthritis. The knowledge gained from these studies will provide new insights into cell-based therapies in autoimmune arthritis, and advance the understanding of fundamental mechanisms underlying T differentiation.

References

Lei F, Zhao B, Haque R, Xiong X, Budgeon L, Christensen N . In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance. Cancer Res. 2011; 71(14):4742-7. DOI: 10.1158/0008-5472.CAN-11-0359. View

Zhao T, Zhang Z, Rong Z, Xu Y . Immunogenicity of induced pluripotent stem cells. Nature. 2011; 474(7350):212-5. DOI: 10.1038/nature10135. View

Peres R, Liew F, Talbot J, Carregaro V, Oliveira R, Almeida S . Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2015; 112(8):2509-14. PMC: 4345589. DOI: 10.1073/pnas.1424792112. View

Lei F, Haque R, Xiong X, Song J . Directed differentiation of induced pluripotent stem cells towards T lymphocytes. J Vis Exp. 2012; (63):e3986. PMC: 3389997. DOI: 10.3791/3986. View

van Herwijnen M, Wieten L, van der Zee R, van Kooten P, Wagenaar-Hilbers J, Hoek A . Regulatory T cells that recognize a ubiquitous stress-inducible self-antigen are long-lived suppressors of autoimmune arthritis. Proc Natl Acad Sci U S A. 2012; 109(35):14134-9. PMC: 3435203. DOI: 10.1073/pnas.1206803109. View

Sharma M, Huang L, Choi J, Lee E, Wilson J, Lemos H . An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor eos. Immunity. 2013; 38(5):998-1012. PMC: 3681093. DOI: 10.1016/j.immuni.2013.01.013. View

Wendorff A, Koch U, Wunderlich F, Wirth S, Dubey C, Bruning J . Hes1 is a critical but context-dependent mediator of canonical Notch signaling in lymphocyte development and transformation. Immunity. 2010; 33(5):671-84. DOI: 10.1016/j.immuni.2010.11.014. View

Bendle G, Linnemann C, Hooijkaas A, Bies L, de Witte M, Jorritsma A . Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy. Nat Med. 2010; 16(5):565-70, 1p following 570. DOI: 10.1038/nm.2128. View

Bacher P, Kniemeyer O, Schonbrunn A, Sawitzki B, Assenmacher M, Rietschel E . Antigen-specific expansion of human regulatory T cells as a major tolerance mechanism against mucosal fungi. Mucosal Immunol. 2013; 7(4):916-28. DOI: 10.1038/mi.2013.107. View

10.

Saito H, Okita K, Chang A, Ito F . Adoptive Transfer of CD8+ T Cells Generated from Induced Pluripotent Stem Cells Triggers Regressions of Large Tumors Along with Immunological Memory. Cancer Res. 2016; 76(12):3473-83. PMC: 4911287. DOI: 10.1158/0008-5472.CAN-15-1742. View

11.

Lei F, Song J, Haque R, Xiong X, Fang D, Wu Y . Transgenic expression of survivin compensates for OX40-deficiency in driving Th2 development and allergic inflammation. Eur J Immunol. 2013; 43(7):1914-24. PMC: 3876962. DOI: 10.1002/eji.201243081. View

12.

Haque R, Lei F, Xiong X, Wu Y, Song J . FoxP3 and Bcl-xL cooperatively promote regulatory T cell persistence and prevention of arthritis development. Arthritis Res Ther. 2010; 12(2):R66. PMC: 2888221. DOI: 10.1186/ar2983. View

13.

Sela U, Olds P, Park A, Schlesinger S, Steinman R . Dendritic cells induce antigen-specific regulatory T cells that prevent graft versus host disease and persist in mice. J Exp Med. 2011; 208(12):2489-96. PMC: 3256961. DOI: 10.1084/jem.20110466. View

14.

Porter D, Levine B, Kalos M, Bagg A, June C . Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med. 2011; 365(8):725-33. PMC: 3387277. DOI: 10.1056/NEJMoa1103849. View

15.

Kuball J, Dossett M, Wolfl M, Ho W, Voss R, Fowler C . Facilitating matched pairing and expression of TCR chains introduced into human T cells. Blood. 2006; 109(6):2331-8. PMC: 1852191. DOI: 10.1182/blood-2006-05-023069. View

16.

Aschenbrenner K, DCruz L, Vollmann E, Hinterberger M, Emmerich J, Swee L . Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat Immunol. 2007; 8(4):351-8. DOI: 10.1038/ni1444. View

17.

Wright G, Notley C, Xue S, Bendle G, Holler A, Schumacher T . Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis. Proc Natl Acad Sci U S A. 2009; 106(45):19078-83. PMC: 2776462. DOI: 10.1073/pnas.0907396106. View

18.

Perro M, Tsang J, Xue S, Escors D, Cesco-Gaspere M, Pospori C . Generation of multi-functional antigen-specific human T-cells by lentiviral TCR gene transfer. Gene Ther. 2010; 17(6):721-32. DOI: 10.1038/gt.2010.4. View

19.

Haque R, Lei F, Xiong X, Bian Y, Zhao B, Wu Y . Programming of regulatory T cells from pluripotent stem cells and prevention of autoimmunity. J Immunol. 2012; 189(3):1228-36. PMC: 3401327. DOI: 10.4049/jimmunol.1200633. View

20.

van Loenen M, de Boer R, Amir A, Hagedoorn R, Volbeda G, Willemze R . Mixed T cell receptor dimers harbor potentially harmful neoreactivity. Proc Natl Acad Sci U S A. 2010; 107(24):10972-7. PMC: 2890759. DOI: 10.1073/pnas.1005802107. View